|
ZNF79 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.238580E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.215900E-02 |
| Normal-vs-Stage2 |
7.784200E-01 |
| Normal-vs-Stage3 |
9.899000E-01 |
| Normal-vs-Stage4 |
1.521960E-02 |
| Stage1-vs-Stage2 |
3.171400E-01 |
| Stage1-vs-Stage3 |
2.562000E-01 |
| Stage1-vs-Stage4 |
5.022000E-01 |
| Stage2-vs-Stage3 |
8.455000E-01 |
| Stage2-vs-Stage4 |
1.643790E-01 |
| Stage3-vs-Stage4 |
1.208650E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.536570E-01 |
| Normal-vs-AfricanAmerican |
2.589700E-02 |
| Normal-vs-Asian |
9.247000E-01 |
| Caucasian-vs-AfricanAmerican |
1.840820E-01 |
| Caucasian-vs-Asian |
7.527600E-01 |
| AfricanAmerican-vs-Asian |
4.553600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.799800E-02 |
| Normal-vs-Female |
6.902800E-01 |
| Male-vs-Female |
1.721980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.269600E-01 |
| Normal-vs-Extreme_Weight |
1.161780E-02 |
| Normal-vs-Obese |
8.414000E-01 |
| Normal-vs-Extreme_Obese |
2.579600E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.748200E-01 |
| Normal_Weight-vs-Obese |
6.918400E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.424200E-01 |
| Extreme_Weight-vs-Obese |
8.060400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
6.103000E-01 |
| Obese-vs-Extreme_Obese |
2.306800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.554800E-01 |
| Normal-vs-Age(41-60Yrs) |
8.038200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.956700E-03 |
| Normal-vs-Age(81-100Yrs) |
2.649600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.518000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.375600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.530980E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.604600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.061900E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.970400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.023900E-02 |
| Normal-VS-Type2 PRCC |
4.036000E-01 |
| Normal-VS-KIRP CIMP |
8.009400E-01 |
| Normal-VS-Unclassified PRCC |
5.834400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.931000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.180200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.801800E-02 |
| Type2 PRCC-VS-KIRP CIMP |
5.714800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.842200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.126200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.052200E-01 |
| Normal-vs-N1 |
7.657800E-01 |
| Normal-vs-N2 |
8.575500E-02 |
| N0-vs-N1 |
6.349800E-01 |
| N0-vs-N2 |
5.109800E-01 |
| N1-vs-N2 |
3.377600E-01 |
|
|
